**Core Concept**
Temozolomide is an oral chemotherapeutic agent that belongs to the class of alkylating agents. It works by inducing DNA cross-links and single-strand breaks, thereby inhibiting tumor cell growth and proliferation.

**Why the Correct Answer is Right**
Temozolomide is particularly effective in the treatment of glioblastoma multiforme, a primary brain cancer. The mechanism of action involves the formation of O6-methylguanine adducts, which prevent DNA repair and trigger apoptosis. Another key aspect of temozolomide's efficacy is its ability to cross the blood-brain barrier, allowing for direct delivery to the tumor site. This is crucial in the treatment of brain cancers, where traditional chemotherapeutic agents often struggle to penetrate the blood-brain barrier.

**Why Each Wrong Option is Incorrect**
* **Option A:** Temozolomide is not primarily used in the treatment of breast cancer. While it has been investigated as a potential treatment for various cancers, its efficacy in breast cancer is not well established.
* **Option B:** Although temozolomide is an alkylating agent, it is not used in the treatment of acute myeloid leukemia (AML). Other chemotherapeutic agents, such as anthracyclines and cytarabine, are more commonly used in AML treatment.
* **Option C:** Temozolomide is not typically used in combination with bevacizumab for the treatment of non-small cell lung cancer (NSCLC). Bevacizumab is an anti-angiogenic agent that is often used in combination with other chemotherapeutic agents for the treatment of NSCLC.

**Clinical Pearl / High-Yield Fact**
Temozolomide is a well-tolerated oral agent that can be administered at home, making it an attractive option for patients with brain cancers. However, it is essential to monitor patients for potential side effects, such as fatigue, nausea, and myelosuppression.

**Correct Answer:** D. Glioblastoma multiforme